Ronald Taylor
0000-0003-1578-8382
4 papers found
Refreshing results…
Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development
‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development
IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions
Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions
Missing publications? Search for publications with a matching author name.